PRNewswire New Delhi [India] January 24 Attentiveai a leading AI-based SaaS startup today announced the successful close of its Series A2 funding round completing a 12M raise in Series A in two tranch ...

UnitedHealth reported fourth-quarter adjusted EPS of $6.81, up from $6.16 a year ago, beating the consensus of $6.72.

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

In a report released today, Greg Harrison from Scotiabank maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a price target of $433.00. The company’s shares ...

Vertex Pharmaceuticals (VRTX) Incorporated announced that the U.S. Food and Drug Administration has approved JOURNAVX, an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor for the ...

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges: variable efficacy vs opioids, generic competition, and entrenched prescriber habits limit near-term potential ...

Jan 30 (Reuters) - The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals ... UK health system to offer cutting-edge gene therapy for sickle cell disease January 31, 2025 ...

The VERTEX 80 and the VERTEX 80v vacuum FT-IR spectrometers from Bruker are based on the actively aligned UltraScan ™ interferometer, which provides PEAK spectral resolution. The precise linear ...

Intel edges higher after revenue projections miss analysts’ estimates, and Chevron posts adjusted earnings below expectations. Vertex Pharmaceuticals could soon capture $10 billion in sales of ...

Vertex AI and high performance computing make ... Aerospace is collaborating with Google Public Sector to leverage its cutting-edge AI and machine learning tools. By combining Aerospace's deep ...